Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Restructuring Costs (2018 - 2019)

Rockwell Medical's Restructuring Costs history spans 2 years, with the latest figure at -$30000.0 for Q4 2019.

  • For Q4 2019, Restructuring Costs changed N/A year-over-year to -$30000.0; the TTM value through Dec 2020 reached -$30000.0, down 107.5%, while the annual FY2019 figure was $400000.0, 61.17% down from the prior year.
  • Restructuring Costs reached -$30000.0 in Q4 2019 per RMTI's latest filing, down from $430000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $1.0 million in Q2 2018 to a low of -$30000.0 in Q4 2019.